Development of a novel modified miR-15a mimic with enhanced therapeutic potential for treatment of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Guo, Shixiang [1 ]
Fesler, Andrew [1 ]
Huang, Wenjie [2 ]
Wang, Yunchao [2 ]
Yang, Jiali [2 ]
Wang, Xianxing [2 ]
Hwang, Ga-Ram [1 ]
Godwin, Matthew [1 ]
Wang, Huaizhi [2 ]
Ju, Jingfang [1 ]
机构：
[1] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Hepatopancreatobilialy Surg, Chongqing, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2592
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Unraveling the complexity of autophagy: Potential therapeutic applications in Pancreatic Ductal Adenocarcinoma
    Gomez, Valentina E.
    Giovannetti, Elisa
    Peters, Godefridus J.
    SEMINARS IN CANCER BIOLOGY, 2015, 35 : 11 - 19
  • [22] Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
    Wang, Xi
    Zhang, Cheng-Sheng
    Dong, Xu-Yuan
    Hu, Yuan
    Duan, Bao-Jun
    Bai, Jun
    Wu, Yin-Ying
    Fan, Lin
    Liao, Xin-Hua
    Kang, Ye
    Zhang, Peng
    Li, Meng-Yang
    Xu, Jiao
    Mao, Zhi-Jun
    Liu, Hui-Tong
    Zhang, Xiao-Long
    Tian, Li-Fei
    Li, En-Xiao
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (07) : 1252 - 1264
  • [23] Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
    Di Carlo, Claudia
    Brandi, Jessica
    Cecconi, Daniela
    WORLD JOURNAL OF STEM CELLS, 2018, 10 (11): : 172 - 182
  • [24] miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy System in Limb Ischemia
    Besnier, Marie
    Shantikumar, Saran
    Anwar, Maryam
    Dixit, Parul
    Chamorro-Jorganes, Aranzazu
    Sweaad, Walid
    Sala-Newby, Graciela
    Madeddu, Paolo
    Thomas, Anita C.
    Howard, Lynsey
    Mushtaq, Sobia
    Petretto, Enrico
    Caporali, Andrea
    Emanueli, Costanza
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 49 - 62
  • [25] GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
    Yang, Sen
    Zhang, Yalu
    Hua, Yuze
    Cui, Ming
    Wang, Mengyi
    Gao, Junyi
    Liu, Qiaofei
    Liao, Quan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options
    Diwakarla, Chandra
    Hannan, Katherine
    Hein, Nadine
    Yip, Desmond
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (13) : 2276 - 2285
  • [27] The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
    Principe, Daniel R.
    Underwood, Patrick W.
    Korc, Murray
    Trevino, Jose G.
    Munshi, Hidayatullah G.
    Rana, Ajay
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
    Hou, Wanting
    Yang, Biao
    Zhu, Hong
    PHARMACEUTICS, 2022, 14 (10)
  • [29] Identification of MYC as a novel repressor of miR-29 in pancreatic ductal adenocarcinoma
    Kwon, Jason
    Quirin, Kayla
    Factora, Tricia
    Kota, Janaiah
    CANCER RESEARCH, 2018, 78 (13)
  • [30] A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
    Tiandong Li
    Junfen Xia
    Huan Yun
    Guiying Sun
    Yajing Shen
    Peng Wang
    Jianxiang Shi
    Keyan Wang
    Hongwei Yang
    Hua Ye
    Cancer Cell International, 23
12345